Frisco Crash Judgment Against Honda for Far-Side Impact Brain and Skull Injuries to a Passenger
After trial: The jury put 77 percent of the fault on the other driver, so judgment was entered against Honda for 23 percent of the award. The Fifth Circuit affirmed in November 2023.
Won by Levinger, P.C. and Turley Law Firm.
A 20-year-old passenger in a 2014 Honda CR-V suffered a crushed skull and permanent brain, face and left-eye injuries when a red-light runner struck the car and her brother's head hit hers. An Eastern District of Texas jury found the CR-V's restraint design defective and awarded her $21,180,808.74, with Honda 23 percent responsible. The judgment of $4,871,586.01 stood and the Fifth Circuit affirmed.
What happened
Su Min Kim was 20 years old on June 30, 2018, riding in the front passenger seat of a 2014 Honda CR-V driven by her younger brother through the intersection of Warren Parkway and Dallas Parkway in Frisco, Texas. He was traveling about 34 mph when another driver, Trae Michael Hubbard, ran a red light at 45 to 50 mph and struck the passenger side of the CR-V.
The impact did not hurt Su Min directly. The force threw her brother's upper body toward the point of impact, and he rolled out of the shoulder portion of his seatbelt. His head moved into the passenger space just as Su Min rebounded off the side airbags, and the two siblings' heads collided. Her brother suffered a minor concussion. Su Min's skull was crushed, and she has permanent injuries to her brain, skull, face and left eye that leave her unable to live independently.
Engineers call this a far-side impact injury: an occupant on the side opposite the collision strikes something inside the vehicle. The Kims sued American Honda Motor Co. in the Eastern District of Texas in May 2019, alleging a defective design under strict liability and negligence theories. Their experts, biomechanical engineer Mariusz Ziejewski and automotive engineer Neil Hannemann, testified that the crash should have been survivable without serious injury and that either a center airbag or a reverse geometry seatbelt, both already in existence, would have prevented it. Honda's corporate representative admitted that before the 2014 CR-V was built, Honda ran no side-impact test with a far-side dummy in the vehicle.
Windle Turley of Turley Law Firm, with Jeffrey Levinger of Levinger, P.C., represented the Kims. Before trial Honda moved to exclude both experts, and after a Daubert hearing the district court found the challenges went to weight rather than admissibility. The court also refused Honda's request for a jury instruction presuming it was not liable for complying with federal standards, because no federal standard governs the risk of a far-side injury in a near-side collision.
The jury found Honda liable for a defective design in 2022 and awarded Su Min $21,180,808.74, along with a smaller separate award to her brother. It assigned 77 percent of the responsibility to Hubbard and 23 percent to Honda, and the final judgment was reduced accordingly to $4,871,586.01 for Su Min. The district court denied Honda's motions for judgment as a matter of law and for a new trial in a 61-page published opinion.
Honda appealed. On November 7, 2023, the Fifth Circuit affirmed, holding that the experts were properly admitted and that the presumption instruction was correctly refused.
Sources
This account is drawn from contemporaneous public reporting and the court record.
- 1.Kim v. American Honda Motor Co., No. 22-40790 (5th Cir. Nov. 7, 2023)·Archived copy
- 2.Kim v. American Honda Motor Co., No. 22-40790, Fifth Circuit opinion, Nov. 7, 2023·Archived copy
- 3.Kim v. Honda Canada, Inc., No. 4:19-cv-00332 (E.D. Tex.), docket
- 4.Gravier House, U.S. Fifth Circuit Affirms Verdict Against Honda, Nov. 18, 2023·Archived copy
More proven verdicts from Turley Law Firm
All Turley Law Firm proven verdicts →A Dallas jury returned a $119.6 million verdict against the Catholic Diocese of Dallas after finding it grossly negligent and fraudulent in concealing years of sexual abuse by priest Rudy Kos; eight of the eleven plaintiffs, represented by Windle Turley, later settled for $23.4 million.
A Dallas County jury awarded $17.5 million to David Fitzgerald, a former maintenance worker who lost both arms and both legs after his infectious disease physician administered eight ineffective antibiotics while never prescribing the one drug that would have stopped his MRSA infection.
Windle Turley filed a $400 million federal lawsuit in Dallas on behalf of former Hare Krishna boarding-school students who suffered rape, physical torture, and emotional abuse as children; the litigation resolved in 2005 through a California bankruptcy court settlement paying $9.5 million to hundreds of victims.
Windle Turley won a $10.15 million jury verdict against Freightliner after the company's lightweight aluminum saddle-tank fuel system ruptured and ignited in a 1974 Texas rollover, killing a husband and wife and leaving their children orphaned. After a decade of appeals, the punitive-damages liability was upheld but the amount was reduced to $450,000.
Related product liability verdicts
Sullivan Papain was among the firms representing New York State against Philip Morris, R.J. Reynolds, Brown & Williamson, and Lorillard, securing a $25 billion recovery through the 1998 Master Settlement Agreement.
C. Steven Yerrid, the youngest of Florida's 11-lawyer 'Dream Team,' added racketeering and conspiracy charges that tripled the damages ceiling, helping the state secure what was then the largest civil settlement in American history against the tobacco industry.
As co-lead counsel in the federal Roundup multidistrict litigation and the first firm to sue Monsanto in 2015, Weitz and Luxenberg helped negotiate a $10.9 billion settlement resolving approximately 125,000 non-Hodgkin lymphoma claims against Bayer-owned Monsanto.
After fifteen years of litigation and three failed bankruptcy maneuvers by Johnson and Johnson subsidiaries, Ashcraft and Gerel attorneys R. Bryant McCulley and Michelle Parfitt helped negotiate a global, uncapped settlement of at least $5.5 billion covering approximately 76,000 ovarian-cancer claims.